Stay updated on Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial
Sign up to get notified when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.

Latest updates to the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page
- Check6 days agoChange DetectedA new revision label (Revision: v3.5.4) was added to the record history, and the previous label (Revision: v3.5.3) was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision history shows a new page version, from v3.5.2 to v3.5.3, indicating a minor update to the record's metadata.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 in the study record history.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision v3.5.0 was added to the record history, replacing the previous v3.4.3 entry. This is a metadata update to the history and does not alter the study content or data displayed on the page.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry, v3.4.3, was added to the history. The prior entry, v3.4.2, was removed from the current view.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision: v3.4.2 was added to the history, and the notice about a lapse in government funding as well as Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.